论文部分内容阅读
目的:探析给予布地奈德与沙丁胺醇雾化吸入联合治疗支气管哮喘急性发作的临床疗效。方法:将我院收治的支气管哮喘急性发作的50例患者,随机分为对照组和观察组,各25例。两组同时给予常规抗感染、化痰给药治疗,其中对照组给予沙丁胺醇雾化吸入治疗,观察组给予布地奈德与沙丁胺醇联合雾化吸入治疗,观察两组效果并进行比较。结果:观察组的总有效率明显高于对照组,且差异具有统计学意义,(P<0.05)。结论:给予患者常规抗感染、化痰给药治疗的基础上,使用布地奈德与沙丁胺醇联合雾化吸入治疗支气管哮喘急性发作患者,取得了显著的效果,因而值得我们临床上借鉴推广。
Objective: To investigate the clinical efficacy of budesonide and salbutamol inhalation in the treatment of acute exacerbation of bronchial asthma. Methods: Fifty patients with acute exacerbation of bronchial asthma admitted to our hospital were randomly divided into control group and observation group, with 25 cases each. The two groups were given conventional anti-infective and phlegm treatment, the control group was given inhalation of salbutamol inhalation, the observation group was given budesonide combined with salbutamol inhalation therapy, the two groups were observed and compared. Results: The total effective rate of the observation group was significantly higher than that of the control group, and the difference was statistically significant (P <0.05). CONCLUSION: Based on routine anti-infective and phlegm-based therapy, the combination of budesonide with salbutamol and nebulized inhalation for the treatment of patients with acute exacerbation of bronchial asthma has achieved remarkable results, which is worth our clinical reference.